4-Methylthioethylamphetamine
| Clinical data | |
|---|---|
| Drug class | serotonin reuptake inhibitor; monoamine oxidase inhibitor |
| ATC code |
|
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C12H19NS |
| Molar mass | 209.35 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
4-Methylthioethylamphetamine (4-MTEA) is a moderately potent serotonin reuptake inhibitor and a moderately potent reversible monoamine oxidase A inhibitor from the substituted amphetamine family; it is either an N-ethyl derivative of amphetamine or an N-ethylamfetamine derivative with an ethylthio group at the 4-position of the benzene ring.[1][2][3]
Pharmacology
[edit]Pharmacodynamics
[edit]MTEA acts as a monoamine reuptake inhibitor; at least, it is known to moderately inhibit the serotonin transporter with an IC50 value of 0.963 ± 0.076 µM (963 nM), which in the study indicated an inhibitory potency nearly equal to that of 3,4-methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine, although no human or animal studies have been conducted to confirm its empathogenic effect.[1] MTEA acts as a moderate-potency reversible monoamine oxidase А inhibitor with an IC50 value of 1.80 ± 0.24 µM and no effect on MAO-B.[2][3]
References
[edit]- 1 2 Cloonan SM, Keating JJ, Butler SG, Knox AJ, Jørgensen AM, Peters GH, et al. (December 2009). "Synthesis and serotonin transporter activity of sulphur-substituted alpha-alkyl phenethylamines as a new class of anticancer agents". European Journal of Medicinal Chemistry. 44 (12): 4862–4888. doi:10.1016/j.ejmech.2009.07.027. hdl:2262/32166. PMID 19717215.
- 1 2 Hurtado-Guzmán C, Fierro A, Iturriaga-Vásquez P, Sepúlveda-Boza S, Cassels BK, Reyes-Parada M (August 2003). "Monoamine oxidase inhibitory properties of optical isomers and N-substituted derivatives of 4-methylthioamphetamine". Journal of Enzyme Inhibition and Medicinal Chemistry. 18 (4): 339–347. doi:10.1080/1475636031000118437. PMID 14567549.
- 1 2 Reyes-Parada M, Iturriaga-Vasquez P, Cassels BK (2019). "Amphetamine Derivatives as Monoamine Oxidase Inhibitors". Frontiers in Pharmacology. 10 1590. Frontiers. doi:10.3389/fphar.2019.01590. PMC 6989591. PMID 32038257.
| DATTooltip Dopamine transporter (DRIsTooltip Dopamine reuptake inhibitors) |
| ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NETTooltip Norepinephrine transporter (NRIsTooltip Norepinephrine reuptake inhibitors) |
| ||||||||||||||
| SERTTooltip Serotonin transporter (SRIsTooltip Serotonin reuptake inhibitors) |
| ||||||||||||||
| VMATsTooltip Vesicular monoamine transporters | |||||||||||||||
| Others |
| ||||||||||||||
| Non-specific |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phenethylamines (dopamine, epinephrine, norepinephrine) |
| ||||||||||
| Tryptamines (serotonin, melatonin) |
| ||||||||||
| Histamine |
| ||||||||||
- Articles with short description
- Short description is different from Wikidata
- Infobox drug articles with non-default infobox title
- Chemical articles without CAS registry number
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes